Stay updated on Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial page.

Latest updates to the Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now shows the ClinicalTrials.gov frontend revision updated to v3.5.3 instead of v3.5.2.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedPage revision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check52 days agoChange DetectedSite revision label updated from v3.4.2 to v3.4.3 in the page footer.SummaryDifference0.1%

- Check80 days agoChange DetectedAdded Revision: v3.4.2 and removed prior notices about government funding lapse and operating status, including removal of Revision: v3.4.1.SummaryDifference0.5%

- Check87 days agoChange DetectedA site-wide funding notice was added and the revision label updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

Stay in the know with updates to Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial page.